NCT01128530 - Efficacy and Safety Study of JNJ-32729463 for Treating Complicated Skin and Skin Structure Infections Compared to Linezolid (Zyvox) | Biotech Hunter

Enrollment

161

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

January 31, 2011

Conditions

Complicated Skin and Skin Structure Infections

Interventions

DRUG

JNJ-32729463

250 mg tablet twice daily

DRUG

linezolid

600 mg tablet twice daily

DRUG

JNJ-32729463 placebo

1 placebo tablet twice daily

DRUG

linezolid placebo

1 placebo tablet, twice daily

Trial Locations (27)

19107

Furiex Research Site, Philadelphia

31406

Furiex Research Site, Savannah

31904

Furiex Research Site, Columbus

33912

Furiex Research Site, Fort Myers

34741

Furiex Research Site, Kissimmee

34769

Furiex Research Site, Saint Cloud

43608

Furiex Research Site, Toledo

48202

Furiex Research Site, Detroit

48320

Furiex Research Site, Keego Harbor

59701

Furiex Research Site, Butte

60048

Furiex Research Site, Libertyville

70112

Furiex Research Site, New Orleans

70663

Furiex Research Site, Sulphur

70809

Furiex Research Site, Baton Rouge

77002

Furiex Research Site, Houston

77005

Furiex Research Site, Houston

77498

Furiex Research Site, Sugar Land

77598

Furiex Research Site, Webster

83404

Furiex Research Site, Idaho Falls

90620

Furiex Research Site, Buena Park

90813

Furiex Research Site, Long Beach

91911

Furiex Research Site, Chula Vista

91942

Furiex Research Site, La Mesa

92056

Furiex Research Site, Oceanside

92701

Furiex Research Site, Santa Ana

92708

Furiex Research Site, Fountain Valley

92804

Furiex Research Site, Anaheim